---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-010684"
form_type: "8-K/A"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2023-05-31T23:59:59+00:00"
generated_at: "2026-06-14T10:43:57.199056+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Harmony Biosciences grants CEO Dayno 125,000 options in promotion compensation

## Summary
- 125,000 options granted under 2020 Incentive Award Plan effective May 26, 2023.
- 50% of shares vest on May 25, 2025; remainder in 24 monthly installments starting June 25, 2025.
- Vesting conditioned on Dr. Dayno's continued service through each vesting date.
- Amendment provides details omitted from original April 24, 2023 8-K announcing Dayno's promotion to President and CEO.

## SEC filing metadata
- accession: 0001558370-23-010684
- form_type: 8-K/A
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2023-05-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000155837023010684/0001558370-23-010684-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000155837023010684/hrmy-20230424x8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-010684
- JSON: https://secwatch.observer/filing/0001558370-23-010684.json
- Plain text: https://secwatch.observer/filing/0001558370-23-010684.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.